University of Birmingham
Biomarkers predict outcomes in patients with atrial fibrillation and cardiovascular conditions
Abstract
dc:description.abstractAtrial fibrillation (AF) is the most common sustained cardiac arrhythmia with a prevalence of 3-4%. Thirteen cardiovascular biomarkers selected in a Delphi process were centrally quantified on high-precision, high-throughput analysers (Roche Diagnostics, Penzberg, Germany) in 1620 patients recruited into Birmingham Black Country Atrial Fibrillation Registry at Sandwell and West Birmingham NHS Trust. Follow-up information on outcomes (cardiovascular death, heart failure hospitalization, stroke or systemic embolism and acute coronary syndrome) were obtained using health records and central mortality data from NHS digital. Follow-up was for a median of 4.2 (IQR 3.5–4.9) years with analysis performed at 2.5 years. Clinical characteristics and biomarker concentrations were related to outcomes. Study 1 examines the value of NT-proBNP in predicting cardiovascular death or heart failure hospitalization in phenotype groups based on AF and heart failure status. Study 2 examines biomarker predictors and clinical predictors of major adverse cardiovascular events (MACE) in patients with cardiovascular conditions.
Degree
thesis:*- Name dc:type.qualificationname
- h_md
- Level dc:type.qualificationlevel
- h_md
- Grantor dc:publisher.institution
- University of Birmingham
- Year dc:date.issued
- 2022
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Brady, Paul
Subjects
dc:subject × 2Rights
- Language dc:language.dcterms_iso639_2
- eng